Blood Res.  2022 Sep;57(3):235-238. 10.5045/br.2022.2022095.

Comparative evaluation of the developed targeted RNA sequencing system and a commercialized test panel

• Lee YE
• Park JH
• Lim HJ
• Kim HR
• Shin JH
• Shin MG

• KMID: 2533252
• DOI: http://doi.org/10.5045/br.2022.2022095

Figure

• 

  Fig. 1 Frequency of gene fusions detected in various types of leukemia using our targeted RNA-seq system. (A) Black bars indicate the frequency of gene fusions detected in patients with each leukemia type. Gene fusion was detected in 77% (72 patients) of all the 93 leukemia patients. Genetic fusion mutations were observed in 94% (33/35) of adult B-ALL patients and 83% (25/30) of pediatric B-ALL patients. (B) Gene fusion pattern and frequency for each type of leukemia. Among the gene fusions found in adult B-ALL (N=35), the most common fusion gene was BCR-ABL1 (24/33, 73%), and the most common fusion gene mutation in childhood B-ALL was ETV6-RUNX1 (4/26, 15%). Abbreviation: RNA-seq, RNA sequencing.

Reference

1. Kim HR, Kang MG, Lee YE, et al. 2018; Spectrum of mitochondrial genome instability and implication of mitochondrial haplogroups in Korean patients with acute myeloid leukemia. Blood Res. 53:240–9. DOI: 10.5045/br.2018.53.3.240. PMID: 30310792. PMCID: PMC6170299.

2. Park JH, Kang MG, Kim HR, et al. 2020; Changing the frequency and spectra of chromosomal aberrations in Korean patients with acute leukemia in a tertiary care hospital. Blood Res. 55:225–45. DOI: 10.5045/br.2020.2020255. PMID: 33303709. PMCID: PMC7784131.

3. Lim HJ, Lee JH, Lee SY, et al. 2021; Diagnostic validation of a clinical laboratory-oriented targeted RNA sequencing system for detecting gene fusions in hematologic malignancies. J Mol Diagn. 23:1015–29. DOI: 10.1016/j.jmoldx.2021.05.008. PMID: 34082071.

4. Engvall M, Cahill N, Jonsson BI, Höglund M, Hallböök H, Cavelier L. 2020; Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics. BMC Med Genomics. 13:106. DOI: 10.1186/s12920-020-00739-4. PMID: 32727569. PMCID: PMC7388219. PMID: 5e85005c5d9c4e89b00736435ddcd638.

5. Jain N, Roberts KG, Jabbour E, et al. 2017; Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood. 129:572–81. DOI: 10.1182/blood-2016-07-726588. PMID: 27919910. PMCID: PMC5290985.

6. El-Menshawy N, Abd-Aziz SM, Elkhamisy EM, Ebrahim MA. 2018; Leukemia propagating cells in Philadelphia chromosome-positive ALL: a resistant phenotype with an adverse prognosis. Blood Res. 53:138–44. DOI: 10.5045/br.2018.53.2.138. PMID: 29963520. PMCID: PMC6021579.